DARA BioSciences, Inc. (DARA)

[macjockey]

My opinion: on May 23 a huge amount of Dara was traded based on rumors that GSK was going to acquire them. I think that some private traders or hedge funds acquired and sat for a few months to see what shook out and now you are seeing sell off over the last eight weeks as they put the powder back to work elsewhere. Dara is oversold at these levels, and has all the same upside from May in addition to a Q2 that demonstrated earning potential. Q3 should cement that, and with KRN double orphan on the horizon this stock could easily be trading over two dollars.